Showing results (31-40 of 998) with videos related to
Sort By:
Pageof 100
Urologic Oncology|July 4, 2009
Candidate quality of care indicators for localized bladder cancerMatthew R Cooperberg, Michael P Porter, Badrinath R KonetyJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2010
Time trends and local variation in primary treatment of localized prostate cancerMatthew R Cooperberg, Jeanette M Broering, Peter R CarrollCurrent Oncology Reports|March 30, 2016
Clinical Utility of Biomarkers in Localized Prostate CancerMichael S Leapman, Hao G Nguyen, Matthew R CooperbergCurrent Opinion in Urology|March 12, 2014
Meaningful end points and outcomes in men on active surveillance for early-stage prostate cancerChristopher J Welty, Matthew R Cooperberg, Peter R CarrollThe Journal of Urology|July 24, 2007
Chemoprevention of prostate cancer: agents and study designsIan M ThompsonThe Journal of Urology|November 7, 2006
Defining high risk prostate cancer--where do we set the bar? A translational science approach to risk stratificationIan M ThompsonAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Overdiagnosis and overtreatment of prostate cancerIan M ThompsonDrugs of Today (Barcelona, Spain : 1998)|May 24, 2003
Pharmacologic agents in complementary medicine in prostatic diseaseIan M. ThompsonJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 17, 2011
Androgen deprivation therapy and cardiovascular riskSanoj Punnen, Matthew R Cooperberg, Natalia Sadetsky, et al.Biorxiv : the Preprint Server for Biology|June 9, 2020
Expression of ACE2, the SARS-CoV-2 receptor, and TMPRSS2 in prostate epithelial cellsHanbing Song, Bobak Seddighzadeh, Matthew R Cooperberg, et al.Pageof 100